Results 1 to 10 of about 6,665,898 (305)

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version) [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Recently, advances in organoid technology have opened new avenues for the development of novel models of human cancer. Patient-derived tumor organoids retain phenotypes such as histopathological, genetic and molecular features of the original tumor.
The Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association, The Society of Cancer Endocrinology, China Anti-Cancer Association
doaj   +3 more sources

Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients

open access: yesJournal of the National Cancer Center, 2021
Breast cancer in young females is a relatively common disease in China. Young breast cancer has aggressive clinical and pathological features. During the treatment of young females with breast cancer, issues involving the choice of surgical methods ...
Committee of Diagnosis, Treatment, and Fertility Management of Chinese Young Breast Cancer Patients
doaj   +1 more source

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

open access: yesScientific Reports, 2023
Role of DNA damage and demethylation on anticancer activity of DNA methyltransferase inhibitors (DNMTi) remains undefined. We report the effects of DNMT1 gene deletion/disruption (DNMT1 −/− ) on anticancer activity of a class of DNMTi in vitro, in vivo ...
Angelo B. A. Laranjeira   +5 more
doaj   +1 more source

Rethinking Oncologic Treatment Strategies with Interleukin-2

open access: yesCells, 2023
High-dose recombinant human IL-2 (rhIL-2, aldesleukin) emerged as an important treatment option for selected patients with metastatic melanoma and metastatic renal cell carcinoma, producing durable and long-lasting antitumor responses in a small fraction
Brian Ko   +4 more
doaj   +1 more source

Diagnosis of ovarian cancer [PDF]

open access: yesBMJ, 2015
#### The bottom line Ovarian cancer is the seventh most common cancer in women worldwide, with 239 000 new cases diagnosed in 2012.1 As with many other types of cancer, geographical variation in the incidence of and mortality from ovarian cancer is substantial, with a higher incidence in economically developed regions of the world.2 Incidence is ...
Sundar, S, Neal, RD, Kehoe, S
openaire   +3 more sources

China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)

open access: yesChinese Journal of Lung Cancer, 2023
Lung cancer is the leading cause of cancer-related death in China. The effectiveness of low-dose computed tomography (LDCT) screening has been further validated in recent years, and significant progress has been made in research on identifying high-risk ...
Chinese Expert Group on Early Diagnosis and Treatment of Lung Cancer   +1 more
doaj   +1 more source

Effects of MRE11 on Apoptosis and Proliferation of Esophageal Squamous Cancer Cells

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the effect of MRE11 on the proliferation and apoptosis of esophageal squamous cancer cells and its molecular mechanism. Methods MRE11 expression was downregulated by MRE11 siRNA transfection in esophageal squamous cancer cells ...
ZHANG Yan   +4 more
doaj   +1 more source

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

open access: yesJournal of Hematology & Oncology, 2021
Background Challenges remain on the selection of patients who potentially respond to a class of drugs that target epigenetics for cancer treatment. This study aims to investigate TET2/DNMT3A mutations and antitumor activity of a novel epigenetic agent in
Sherry X. Yang   +7 more
doaj   +1 more source

The Society of Cancer Precision Medicine of Chinese Anti-Cancer Association

open access: yesChinese Journal of Lung Cancer, 2023
RNA-based next-generation sequencing (NGS) has been recommended as a method for detecting fusion genes in non-small cell lung cancer (NSCLC) according to clinical practice guidelines and expert consensus.
China Primary Health Care Foundation Tumor Precision Diagnosis and Treatment Committee   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy